Current as of September 28, 2026. General information, not medical or legal advice.
Short answer: If you are in uniform, do not use it. BPC-157 is not an approved drug anywhere in the world, it is not a legal supplement ingredient, it is on the World Anti-Doping Agency's prohibited list at all times, and it is on the DoD prohibited dietary supplement ingredients list. The instruction covering that list says service members can be prosecuted for using products containing substances on it.
We do not sell peptides. This post exists because the marketing is everywhere and the consequences land on you, not the seller.
What the FDA actually said, this year
In May 2026 the FDA published a briefing document on BPC-157 ahead of an advisory committee meeting. Its language is unusually plain.
There is no approved product containing BPC-157 in any country at this time, and it does not appear in the European, Japanese or international pharmacopeias.
There is no United States Pharmacopeia monograph for it, and it is not a component of any FDA-approved drug. That matters more than it sounds: those are the qualifying routes for a substance to be compounded lawfully, and BPC-157 fails all of them.
The agency also found no studies that administered BPC-157 to humans by the oral, subcutaneous, nasal or transdermal routes people actually use.
On the science: not well characterized from a physical and chemical standpoint, and as a 15 amino acid peptide given by injection or nasally, a significant risk for immunogenicity, meaning your immune system reacting to it.
Reported adverse events include injection site reactions, shortness of breath, and diffuse hyperpigmentation with darkening of the gums.
The entire human efficacy base is one trial of 53 subjects over two weeks, given as a rectal enema, published only as a meeting abstract. The FDA's assessment was that the data are inadequate to support efficacy and safety. And the indication under evaluation was ulcerative colitis, not the tendon and ligament healing it is marketed for.
The FDA's own recommendation was against adding it to the compounding list.
About that advisory vote
In July 2026 the advisory committee voted to recommend BPC-157 anyway, against the FDA staff position. You will see that cited by sellers.
Three things about it. Advisory committee votes are recommendations and are not binding. The FDA has issued no rule changing anything. And the codified list of substances that may be used in this kind of compounding contains six substances, none of them peptides.
So nothing about the legal position changed in July.
Why it is different for you
The DoD instruction on dietary supplements, effective March 2022, says service members are prohibited from using any dietary supplement containing ingredients on the prohibited list, and that service members can be prosecuted under the Uniform Code of Military Justice for doing so. It also directs each service to issue an enforceable, punitive regulation.
BPC-157 is on that list. We checked the live database rather than trusting a secondhand claim, and it returns as prohibited, with the reason given as the anti-doping list's category of non-approved substances.
The anti-doping list names it directly rather than sweeping it up in a catch-all: prohibited at all times, in and out of competition.
One thing we will not tell you is whether it shows up on a urinalysis. We could not verify that either way, and it does not matter much. The prohibition is on use, not on testing positive.
The "research use only" label is not a shield
Sellers put research-use-only on the vial and believe that solves it.
The FDA has addressed this directly. In a 2023 warning letter to a company selling injectable and nasal BPC-157, the agency wrote that despite statements marketing the products for research purposes only and not for human consumption, evidence from the website established the products were intended to be drugs for human use.
Other letters name BPC-157 alongside ipamorelin and CJC-1295, with the same conclusion: not eligible for the compounding exemptions because they are not the subject of a pharmacopeia monograph, are not components of an approved drug, and are not on the list.
One company was selling a BPC-157 product marketed for COVID-19.
The other peptides in the same conversation
CJC-1295. The FDA has identified serious adverse events including increased heart rate and a systemic vasodilatory reaction, with limited clinical data. On the DoD prohibited list.
Ipamorelin. The FDA cites a published study identifying serious adverse events including death when it was given intravenously for gastric motility. On the DoD prohibited list.
Sermorelin. Its actual approved indications were growth hormone deficiency in children with growth failure, and a pituitary function test. Nothing to do with adult recovery or anti-aging. On the DoD prohibited list, flagged as a discontinued drug.
Tesamorelin. This is the sharpest example. It is an FDA-approved prescription drug, approved for HIV-associated lipodystrophy. It is still prohibited under anti-doping rules and still on the DoD prohibited list. Approved does not mean permitted for you.
If you are already using it
Stop, and talk to a physician rather than a forum. Bring what you took and where you got it.
If you are facing an investigation or an adverse action, talk to a defense attorney or legal assistance before you talk to anyone else. That is not our lane.
Questions people actually ask
Is BPC-157 legal? It is not an approved drug in any country, it is not a lawful dietary supplement ingredient, and it cannot lawfully be compounded because it meets none of the qualifying routes.
Is BPC-157 banned in the military? It is on the DoD prohibited dietary supplement ingredients list, and the governing instruction says service members can be prosecuted under the UCMJ for using products containing listed substances.
The advisory committee voted for it in 2026. Did that legalize it? No. Those votes are non-binding, the FDA recommended against it, and no rule has issued.
Will it show up on a drug test? We could not verify that either way and will not guess. The prohibition applies to use regardless.
What about sermorelin or CJC-1295? Also on the DoD prohibited list. Tesamorelin is FDA-approved for a specific HIV-related condition and is still prohibited for service members.
Where we fit
We do not prescribe peptides, and we would not market them to a service member if we did. Our lane is diagnosed hormone deficiency, treated with approved medication, with the labs to back it up.
If someone has been selling you peptides for recovery, we are happy to look at what is actually going on instead.
Discounted pricing for military, law enforcement and first responders. Request a consultation at hewhealth.com or call (850) 820-8850.
Hew Health, LLC is a private medical practice. We are not affiliated with, endorsed by, or connected to the Department of Defense or the FDA. General information about public regulatory positions as of September 28, 2026, not medical or legal advice. Nothing here is a recommendation to use any unapproved substance.
Sources: FDA Briefing Document, Pharmacy Compounding Advisory Committee, July 23-24 2026, BPC-157-related bulk drug substances, FDA memo dated May 11, 2026, docket FDA-2025-N-6895; meeting notice at 91 FR 20465, April 16, 2026. 21 U.S.C. 353a(b)(1)(A)(i) and 21 CFR 216.23. FDA warning letters to Warrior Labz SARMS (655280, June 12, 2023), Tailor Made Compounding (594743, April 1, 2020), Prescription Dispensing Laboratories (579286, July 30, 2019) and Predator Nutrition (607136, October 23, 2020). DoDI 6130.06, Use of Dietary Supplements in the DoD, effective March 9, 2022, paragraphs 1.2.c, 1.2.d, 2.9.c and 3.2.b. DoD Prohibited Dietary Supplement Ingredients List via Operation Supplement Safety, list updated May 26, 2026. WADA 2026 Prohibited List, class S0, effective January 1, 2026. Sermorelin indications at 78 FR 14095.